OCREVUS

Concentrate for solution for infusion, 300mg/10ml
RxActive license

Active substance (INN)

ocrelizumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength300mg/10ml
PackagingUkupno 1 bočica staklena sa 10ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerF.Hoffmann-La Roche Ltd., Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L04AG08)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateJune 7, 2024

Analogs in Montenegro

1

Other medicines with the same active substance

OCREVUSRx
Solution for injection, 920mgF. Hoffmann-La Roche AG
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026